Vesalius Therapeutics, a company pioneering a revolutionary platform to deliver breakthrough treatments for common diseases, ...
Researchers at Tel Aviv University (TAU) discovered a new factor in the pathology of Parkinson's disease, which in the future ...
Analysis suggests that the research and development of DMTs and non-motor therapies will diversify Parkinson's treatment ...
discovered a new factor in the pathology of Parkinson's disease, which in the future may serve as a target for developing new ...
Researchers are using functionalized nanodiamonds to precisely monitor neuronal activity at the cellular level, enhancing ...
Nir Giladi from TAU’s Faculty of Medical and Health Sciences and the Tel Aviv Sourasky Medical Center, as well as other researchers from TAU and the University of Haifa. The study was backed by the ...
A team of researchers from the University of Barcelona and the Bellvitge Biomedical Research Institute (IDIBELL) has identified a potential biomarker of Parkinson's disease progression.
The researchers note that, "despite the similarities, patients with these diseases have a different prognosis and do not respond to levodopa, the main treatment for Parkinson's disease. Therefore, the ...
Hyperbaric oxygen therapy has long been used to combat compression sickness in divers. But at a hospital in Israel they're using it to address a very different malady - post-traumatic stress disorder ...
The researchers note that, "despite the similarities, patients with these diseases have a different prognosis and do not ...
Management of axial signs (postural instability, freezing) and cognitive decline in Parkinson's disease is unsatisfactory with the current medical treatment. Subthalamic nucleus stimulation is an ...